H.R. 5686 · 115th Congress

Medicare CHOICE Act of 2018

Stage
Reported from committee
Introduced
2018-05-07
Latest action
2018-06-12 · Reported by the Committee on Energy and Commerce. H. Rept. 115-741, Part I.

Summary

Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018

This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).